Oncology
From the Journals
Bilateral mastectomy reduces second breast cancer risk, but not deaths
The risk of second contralateral breast cancer is low regardless of primary breast cancer therapy, results of a retrospective study show.
Feature
Not all lung cancer patients receive treatment
Reasons include metastasis and refusal, and rates by state vary from 8% to 30%, the American Lung Association reports.
Conference Coverage
KRAS-mutation colon, rectal cancers have distinct survival profiles
Conference Coverage
In rectal cancer, fragmented care linked to lower survival
SAN FRANCISCO – Splitting surgery and radiotherapy between different centers was associated with lower survival
Guidelines
New practice guideline: CRC screening isn’t necessary for low-risk patients aged 50-75 years
For individuals aged 50-79 with no symptoms and an estimated 15-year CRC risk below 3%, no screening is recommended by BMJ Rapid Recommendations...
From the Journals
Colorectal screening cost effective in cystic fibrosis patients
Screening for colorectal cancer in patients with cystic fibrosis is cost effective, and should be started at a younger age and performed more...
From the Journals
Clopidogrel matches aspirin for reducing risk of colorectal cancer
The study authors hypothesize that the chemoprotective effect of low-dose aspirin is mediated mostly through the permanent inactivation of...
From the Journals
Colorectal cancer diagnoses still moving up in younger adults, with no sign of plateau
Incidence increased from 10% to 12% over a decade in the analysis of a large U.S. cancer registry.
News
Treatment for pediatric low-grade glioma is associated with poor cognitive and socioeconomic outcomes
The risk for poor outcomes is greater when treatment includes radiotherapy, compared with surgery alone.
Feature
Affiliate cancer centers: What’s in a name?
Conference Coverage
Nephrectomy may benefit select renal cancer patients based on risk factors
CHICAGO – CARMENA update confirms cytoreductive nephrectomy should not be standard of care for most cases of metastatic renal cell carcinoma.